Monday, April 24, 2017

US FDA News: 25 Percent Dextrose Injection, USP (Infant) by Hospira: Recall - Particulate Matter

Particulate administered to a patient could result in local swelling, irritation of blood vessels or tissue, blockage of blood vessels and/or systemic allergic response to the particulate.
Read more: 25 Percent Dextrose Injection, USP (Infant) by Hospira: Recall - Particulate Matter